It has been about a month since the last earnings report for Penumbra (PEN). Shares have lost about 2.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
With its release date creeping ever closer, the official website for Penumbra: Black Plague has now been unveiled by Paradox Interactive. Black Plague is the second (and final) part of the ...
Zacks Investment Research on MSN
Penumbra (PEN) is an incredible growth stock: 3 reasons why
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth ...
Penumbra PEN shares ended the last trading session 6.2% higher at $197.49. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...
Bank of America launched its coverage of medical device maker Penumbra (NYSE:PEN) with a Buy recommendation on Friday, citing a broader commercial rollout of the company’s latest clot-removal product, ...
Lightning Flash™ 2.0 features advanced computer assisted vacuum thrombectomy (CAVT) software, designed for increased efficiency and sensitivity to enhance removal of venous thrombus and treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results